glp 1 agonist anti inflammatory GLP-1 Drugs: For Multiple Chronic Conditions GLP-1 Receptor Agonists and the

Dehydration represents an important factor, as GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation, leading to volume depletion

Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol

Do not use Saxenda if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences

Exploring SGLT2 Inhibitors SGLT2 inhibitors, including empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), offer a different therapeutic pathway

Retatrutide is not currently FDA-approved as a prescription weight-loss medication